Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
47.45 USD | -5.48% | -7.73% | -1.31% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.31% | 465M | |
+64.65% | 62.59B | |
-2.11% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.88% | 19.09B | |
+3.88% | 13.08B | |
+25.49% | 12.26B | |
+27.62% | 12.05B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing